Sagittarius Life Science (3205) — Capital Reinvestment Ratio
Sagittarius Life Science (3205) has a Capital Reinvestment Ratio of 0.66x as of September 2025, meaning it reinvests 1% of its operating cash flow (NT$125.00K) in capital expenditures (NT$83.00K). Check 3205 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sagittarius Life Science Capital Reinvestment Ratio (2015–2016)
This chart tracks Sagittarius Life Science's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Sagittarius Life Science cash conversion from operations.
Annual Capital Reinvestment Ratio for Sagittarius Life Science (2015–2016)
Year-by-year Capital Reinvestment Ratio for Sagittarius Life Science from 2015 to 2016. See 3205 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.05x | NT$360.37 Million | NT$19.76 Million | ▲ +342.3% |
| 2015 | 0.01x | NT$237.94 Million | NT$2.95 Million | — |